Other

Marina L Erenshtein

Maris M Veveris

Ivars Y Kalvinsh

Edmund Y Lukevits

Gunar A Bremanis

Valdis D Mikazhan

Irene B Antsena

Valeryans Y Kauss

Petr T Trapentsier

Anatoly S Birman

Edit A Pule

Edvard E Liepinsh

Novel compounds, viz. 3-(2,2,2-trisubstituted hydrazinium) propionates have the following general formula: ##STR1## wherein R.sup.1, R.sup.2 and R.sup.3 are an alkyl, a substituted alkyl, a substituted or unsubstituted aryl, an aralkyl or an unsaturated alkyl;

3-(2,2,2-trisubstituted hydrazinium) propionates

A novel pharmaceutical preparation for the treatment of hypertensive disease and myocardial infarction, which comprises as an active ingredient, (1,1-dimethyl-3-oxopyrazolidin-1-io-4-yl)acetate of the following formula: ##STR1## and a pharmaceutically acceptable vehicle.

Pharmaceutical preparation for the treatment of hypertensive disease and

Growing community of inventors

Riga, undefined

Marina L Erenshtein